TherapeuticsMD TXMD
NASDAQ TXMD
$2.06 +0.03 (+1.48%)
At close: Aug 20, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Current Leases (2019 - 2020)

TherapeuticsMD's (TXMD) quarterly Current Leases came in at $2.3 million in Q4 2020, up 50.11% YoY from $1.5 million in Q1 2020, and down 6.25% on a QoQ basis from $2.4 million in Q3 2020.

TherapeuticsMD (TXMD) Current Leases (2019 - 2020) Analysis & Trends

TherapeuticsMD (TXMD) has 2 years of Current Leases data on file, last reported at $2.3 million in Q4 2020.

  • Quarterly Current Leases rose 50.11% year-over-year to $2.3 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $2.3 million (up 50.11% YoY) and the FY2020 annual result came in at $2.3 million, up 50.11% from the prior year.
  • Current Leases retreated to $2.3 million in Q4 2020, from $2.4 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $2.4 million in Q3 2020 to a low of $1.2 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 TherapeuticsMD 23.54 Mn 14.35 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 2.25 Mn
Sep 30, 2020 2.40 Mn
Jun 30, 2020 2.11 Mn
Mar 31, 2020 1.75 Mn
Dec 31, 2019 1.50 Mn
Sep 30, 2019 1.24 Mn
Mar 31, 2019 1.16 Mn